J Clin Microbiol. 1993 July; 31(7): 1715-1725
Major outbreak of pertussis in northern Alberta, Canada: analysis of discrepant direct fluorescent-antibody and culture results by using polymerase chain reaction methodology.
C A Ewanowich,
L W Chui,
M G Paranchych,
M S Peppler,
R G Marusyk and
W L Albritton
Provincial Laboratory of Public Health for Northern Alberta, Edmonton, Canada.
ABSTRACT
A major outbreak of 5,683 cases of pertussis occurred in northern Alberta, Canada, from December 1989 to January 1991. The outbreak highlighted a number of problems with current methods of pertussis diagnosis. In particular, an exceptionally high proportion of direct fluorescent-antibody (DFA)-positive, culture-negative specimens (88.4%) was identified. We took this opportunity to use polymerase chain reaction (PCR) methodology to examine whether the low culture rates were due to specimens containing dead organisms or whether the DFA results represented high numbers of false-positive results. A set of primer sequences within a Bordetella pertussis-specific repetitive element was used to amplify proteinase K extracts of B. pertussis DNA recovered from 279 submitted slides inoculated at the point of collection with nasopharyngeal material obtained from pernasal swabs. The PCR data corroborated the culture results: 84.6% of DFA-positive, culture-negative specimens were similarly PCR negative. At least three different bacterial species that were significantly cross-reactive with the commercial DFA reagent were identified in clinical specimens and in pure culture, providing one possible explanation for the false-positive DFA results. These results and other limitations of current diagnostic techniques underline the urgent need for a new DFA reagent with improved specificity and a standardized means of measuring the patient antibody response for the diagnosis of pertussis.
J Clin Microbiol. 1993 July; 31(7): 1715-1725
This article has been cited by other articles:
-
She, R. C., Billetdeaux, E., Phansalkar, A. R., Petti, C. A.
(2007). Limited Applicability of Direct Fluorescent-Antibody Testing for Bordetella sp. and Legionella sp. Specimens for the Clinical Microbiology Laboratory. J. Clin. Microbiol.
45: 2212-2214
[Abstract]
[Full Text]
-
Register, K. B., Sanden, G. N.
(2006). Prevalence and Sequence Variants of IS481 in Bordetella bronchiseptica: Implications for IS481-Based Detection of Bordetella pertussis. J. Clin. Microbiol.
44: 4577-4583
[Abstract]
[Full Text]
-
Singh, M., Lingappan, K.
(2006). Whooping cough: the current scene.. Chest
130: 1547-1553
[Abstract]
[Full Text]
-
Mattoo, S., Cherry, J. D.
(2005). Molecular Pathogenesis, Epidemiology, and Clinical Manifestations of Respiratory Infections Due to Bordetella pertussis and Other Bordetella Subspecies. Clin. Microbiol. Rev.
18: 326-382
[Abstract]
[Full Text]
-
Hewlett, E. L., Edwards, K. M.
(2005). Pertussis -- Not Just for Kids. NEJM
352: 1215-1222
[Full Text]
-
Baughman, A. L., Bisgard, K. M., Edwards, K. M., Guris, D., Decker, M. D., Holland, K., Meade, B. D., Lynn, F.
(2004). Establishment of Diagnostic Cutoff Points for Levels of Serum Antibodies to Pertussis Toxin, Filamentous Hemagglutinin, and Fimbriae in Adolescents and Adults in the United States. CVI
11: 1045-1053
[Abstract]
[Full Text]
-
Tang, X. L., Peppler, M. S., Irvin, R. T., Suresh, M. R.
(2004). Use of Bispecific Antibodies in Molecular Velcro Assays Whose Specificity Approaches the Theoretical Limit of Immunodetection for Bordetella pertussis. CVI
11: 752-757
[Abstract]
[Full Text]
-
Peppler, M. S., Kuny, S., Nevesinjac, A., Rogers, C., de Moissac, Y. R., Knowles, K., Lorange, M., De Serres, G., Talbot, J.
(2003). Strain Variation among Bordetella pertussis Isolates from Quebec and Alberta Provinces of Canada from 1985 to 1994. J. Clin. Microbiol.
41: 3344-3347
[Abstract]
[Full Text]
-
Lingappa, J. R., Lawrence, W., West-Keefe, S., Gautom, R., Cookson, B. T.
(2002). Diagnosis of Community-Acquired Pertussis Infection: Comparison of Both Culture and Fluorescent-Antibody Assays with PCR Detection Using Electrophoresis or Dot Blot Hybridization. J. Clin. Microbiol.
40: 2908-2912
[Abstract]
[Full Text]
-
Halperin, S. A., Bortolussi, R., Langley, J. M., Eastwood, B. J., De Serres, G.
(1999). A Randomized, Placebo-Controlled Trial of Erythromycin Estolate Chemoprophylaxis for Household Contacts of Children With Culture-Positive Bordetella pertussis Infection. Pediatrics
104: 42e-42
[Abstract]
[Full Text]
-
Loeffelholz, M. J., Thompson, C. J., Long, K. S., Gilchrist, M. J. R.
(1999). Comparison of PCR, Culture, and Direct Fluorescent-Antibody Testing for Detection of Bordetella pertussis. J. Clin. Microbiol.
37: 2872-2876
[Abstract]
[Full Text]
-
Halperin, S. A., Bortolussi, R., Langley, J. M., Miller, B., Eastwood, B. J.
(1997). Seven Days of Erythromycin Estolate Is as Effective as Fourteen Days for the Treatment of Bordetella pertussis Infections. Pediatrics
100: 65-71
[Abstract]
[Full Text]
-
Christie, C., Marx, M. L., Marchant, C. D., Reising, S. F.
(1994). The 1993 Epidemic of Pertussis in Cincinnati -- Resurgence of Disease in a Highly Immunized Population of Children. NEJM
331: 16-21
[Abstract]
[Full Text]
Copyright © 1993 by the American Society for Microbiology. All rights reserved.